Nuvectis Pharma Inc

1
NAS:NVCT (USA)  
$ 5.04 -0.24 (-4.55%) 12:09 AM EST
At Loss
P/B:
8.70
Market Cap:
$ 97.38M
Enterprise V:
$ 80.21M
Volume:
63.74K
Avg Vol (2M):
210.96K
Trade In:
Volume:
63.74K
At Loss
Avg Vol (2M):
210.96K

Business Description

Description
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.64
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
Future 3-5Y EPS without NRI Growth Rate 9.16

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 32.84
9-Day RSI 34.99
14-Day RSI 38.09
6-1 Month Momentum % 22.59
12-1 Month Momentum % -3.08

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.74
Quick Ratio 2.74
Cash Ratio 2.72

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -9.23

Financials (Next Earnings Date:2025-02-05 Est.)

NVCT's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NVCT

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Nuvectis Pharma Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.16
Beta 0
Volatility % 66.54
14-Day RSI 38.09
14-Day ATR ($) 0.903965
20-Day SMA ($) 6.813
12-1 Month Momentum % -3.08
52-Week Range ($) 4.6106 - 12.1
Shares Outstanding (Mil) 19.32

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nuvectis Pharma Inc Filings

Filing Date Document Date Form
No Filing Data

Nuvectis Pharma Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Nuvectis Pharma Inc Frequently Asked Questions

What is Nuvectis Pharma Inc(NVCT)'s stock price today?
The current price of NVCT is $5.04. The 52 week high of NVCT is $12.10 and 52 week low is $4.61.
When is next earnings date of Nuvectis Pharma Inc(NVCT)?
The next earnings date of Nuvectis Pharma Inc(NVCT) is 2025-02-05 Est..
Does Nuvectis Pharma Inc(NVCT) pay dividends? If so, how much?
Nuvectis Pharma Inc(NVCT) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1